Septerna (SEPN) Asset Utilization Ratio (2024 - 2026)

Septerna's quarterly Asset Utilization Ratio came in at 0.12 in Q1 2026, up 5547.46% year-on-year from 0.0 in Q1 2025, and up 62.18% quarter-over-quarter from 0.08 in Q4 2025.

Septerna has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.12 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio rose 5547.46% year-over-year to 0.12; the trailing twelve-month figure through Mar 2026 stood at 0.12 (up 5547.46% YoY), and the FY2025 full-year result was 0.09, up 2285.14% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.12, up from 0.08 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.12 in Q1 2026, with the low at 0.0 in Q2 2025.
  • Average Asset Utilization Ratio over 3 years is 0.04, with a median of 0.02 recorded in 2024.
  • Year-over-year, Asset Utilization Ratio surged 2141.79% in 2025 and soared 5547.46% in 2026.
  • Tracing SEPN's Asset Utilization Ratio over 3 years: stood at 0.0 in 2024, then soared by 2141.79% to 0.08 in 2025, then jumped by 62.18% to 0.12 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.12 (Q1 2026), 0.08 (Q4 2025), and 0.04 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.60
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.47
7 Evaxion A 62.56 Bn 62.54 Bn - 0.29
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.37
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.85
10 Septerna 1.34 Bn 1.34 Bn - 0.12

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.12
Dec 31, 2025 0.08
Sep 30, 2025 0.04
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00